KD-357 Phase III Study

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222145

Enrollment

200

Registered

2013-07-16

Start date

2013-07-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preexposure prophylaxis against rabies

Interventions

investigational material(s) Generic name etc : KD-357 INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : Intramuscular

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)Subjects who are healthy Japanese between 20 and 65 inclusive at the time of obtaining informed consent. (2)Subjects who are able to give written informed consent.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Rabies virus neutralizing antibody seropositive rate	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026